-
Keeping IRB chairs and members updated and well informed can be challenging when an institution's human subjects research is rapidly expanding.
-
As the world faces its first flu pandemic in more than 40 years, researchers say slow, complicated ethics review processes hinder their ability to respond effectively to emerging infectious diseases.
-
Taking steps now to streamline approval processes for fast-moving diseases will better prepare IRBs to handle not just the current H1N1 virus, but future viruses as well, says Raphael Saginur, MD, FRCPC, chief of the infectious disease division and chairman of the research ethics board (REB) at Ottawa Hospital in Ontario.
-
Improving ease of access to potential research data while aggressively protecting identifiable patient information it's a goal that many institutions struggle with.
-
It was clear to IRB coordinators that something had to be done to improve the length of IRB meetings. Some of the four biomedical IRBs at Northwestern University in Chicago, IL, were fairly fast in reviewing protocols, but others took too long.
-
The General Accounting Office (GAO) report on the IRB system's vulnerabilities doesn't just criticize the individual IRBs targeted by the investigation.
-
The Genetic Information Nondiscrimination Act (GINA) of 2008 protects Americans against discrimination in employment and health insurance coverage based on genetic information.
-
The Office for Human Research Protections (OHRP) recently released guidance for IRBs and investigators on how to deal with the new Genetic Information Nondiscrimination Act (GINA).
-
There might not be any shortcuts to creating the most accurate and thorough IRB reviews and meeting minutes, but it is possible to make these consistent and accurate with a well-thought-out process.
-
IRB staff can greatly improve how the IRB meeting minutes are written by following a few helpful hints, experts say.
